Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
shenshuai yingyang
- Development stage
- Preclinical
- Administration
- Oral
01
Overview
肾衰营养胶囊（Shenshuai Yingyang Capsule）是一种中药复方制剂，主要用于慢性肾脏疾病（CKD）相关的蛋白能量消耗（PEW）及骨骼肌萎缩等并发症的辅助治疗。研究显示，该药通过减轻氧化应激和调节自噬过程，有助于改善CKD患者的骨骼肌萎缩状况[2]。其具体成分、生产企业及详细适应症未在公开渠道广泛披露，但属于中医药领域针对肾功能不全患者开发的产品。该制剂通常作为膳食补充剂或辅助用药，而非西医意义上的处方化学药物。
- Brand names
- 肾衰营养胶囊
- Other names
- 肾衰营养胶囊
02
Targets
HIF1A (Hypoxia-inducible factor 1-alpha)
Beyond the preview
Go deeper on shenshuai yingyang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on shenshuai yingyang.